Suppr超能文献

L(d+)转基因小鼠心脏的免疫原性。

Immunogenicity of L(d+) transgenic mouse hearts.

作者信息

Margenthaler J A, Tu F, Otomo N, Shimizu Y, Yu S, Flye M W

机构信息

Department of Surgery, Washington University School of Medicine, St Louis, Mo.

出版信息

Surgery. 2001 Aug;130(2):217-24. doi: 10.1067/msy.2001.115836.

Abstract

BACKGROUND

C57BL/6 mice transfected with the L(d) gene coupled to the alpha-myosin heavy chain promoter result in transgenic mice with L(d) antigen expressed only on cardiac tissue. These transgenic animals allow the examination of immune reactivity against cardiac L(d) by "self" or by adoptively transferred L(d) specific 2C cells, and the response of nontransgenic C57BL/6 mice to the transplanted L(d+) heart.

METHODS

Naïve cardiac L(d+) transgenic mice were examined for evidence of L(d) "autoimmunity." Forty million fresh 2C cells or 2C cells sensitized in vitro for 7 days against Balb/c (L(d+)) + interleukin-2 were also given intravenously to L(d+) transgenic mice. At 5 and 12 days after injection, heart-infiltrating lymphocytes were analyzed by fluorescence-activated cell sorter. The L(d+) transgenic hearts were also transplanted to syngeneic L(d-) nontransgenic C57BL/6 to evaluate the heart's immunogenicity.

RESULTS

Naïve L(d+) transgenic mice did not exhibit any evidence of lymphocytic infiltration on histologic examination. Adoptive transfer of either fresh or in vitro sensitized 2C cells was also unable to reject the native L(d+) heart in transgenic mice (100% of the mice survived long term [more than 60 days]). Sensitization of the L(d+) transgenic mice with a Balb/c skin graft and interleukin-2 pump infusion (7 days) beginning 1 day before 2C cell injection also did not promote rejection of the native L(d+) heart. However, fluorescence-activated cell sorter analysis did reveal that a significantly greater number of in vitro sensitized 2C cells homed to the L(d+), but not L(d-), heart after both 5 and 12 days (P <.01, P <.001). In contrast, C57BL/6 mice rejected the L(d+) (C57BL/6 background) transgenic heart in a mean survival time of 17 +/- 9.7 days (P <.01), whereas a syngeneic C57BL/6 heart transplant was accepted indefinitely. Lymphocytic infiltration consistent with rejection was present in all animals receiving an Ld+ transgenic heart transplant, whereas no infiltrate was present in those receiving a syngeneic C57BL/6 heart transplant.

CONCLUSIONS

Although the class I L(d) transgene is not recognized in its native host, its immunogenicity is shown by the homing of anti-L(d) 2C cells to the heart in situ and rejection of L(d+) heart grafts when transplanted into syngeneic C57BL/6 mice.

摘要

背景

用与α-肌球蛋白重链启动子偶联的L(d)基因转染C57BL/6小鼠,可产生仅在心脏组织表达L(d)抗原的转基因小鼠。这些转基因动物可用于检测针对心脏L(d)的“自身”免疫反应,或通过过继转移L(d)特异性2C细胞检测免疫反应,以及检测非转基因C57BL/6小鼠对移植的L(d+)心脏的反应。

方法

对未经处理的心脏L(d+)转基因小鼠进行检查,以寻找L(d)“自身免疫”的证据。还将4000万个新鲜的2C细胞或体外致敏7天的2C细胞静脉注射给L(d+)转基因小鼠,这些2C细胞是针对Balb/c(L(d+))+白细胞介素-2致敏的。在注射后第5天和第12天,通过荧光激活细胞分选仪分析心脏浸润淋巴细胞。还将L(d+)转基因心脏移植到同基因的L(d-)非转基因C57BL/6小鼠体内,以评估心脏的免疫原性。

结果

未经处理的L(d+)转基因小鼠在组织学检查中未表现出任何淋巴细胞浸润的证据。过继转移新鲜的或体外致敏的2C细胞也无法排斥转基因小鼠的天然L(d+)心脏(100%的小鼠长期存活[超过60天])。在注射2C细胞前1天开始用Balb/c皮肤移植和白细胞介素-2泵输注(7天)使L(d+)转基因小鼠致敏,也未促进对天然L(d+)心脏的排斥。然而,荧光激活细胞分选仪分析确实显示,在第5天和第12天后,显著更多的体外致敏2C细胞归巢到L(d+)心脏,而不是L(d-)心脏(P<.01,P<.001)。相比之下,C57BL/6小鼠排斥L(d+)(C57BL/6背景)转基因心脏,平均存活时间为17±9.7天(P<.01),而同基因C57BL/6心脏移植则被无限期接受。所有接受Ld+转基因心脏移植的动物均出现与排斥一致的淋巴细胞浸润,而接受同基因C57BL/6心脏移植的动物则未出现浸润。

结论

虽然I类L(d)转基因在其天然宿主中未被识别,但其免疫原性通过抗L(d) 2C细胞归巢到原位心脏以及将L(d+)心脏移植到同基因C57BL/6小鼠体内时被排斥而得以体现。

相似文献

1
Immunogenicity of L(d+) transgenic mouse hearts.L(d+)转基因小鼠心脏的免疫原性。
Surgery. 2001 Aug;130(2):217-24. doi: 10.1067/msy.2001.115836.
5
Regional oral tolerance in transgenic 2C mice.转基因2C小鼠的局部口腔耐受性
Surgery. 2005 Aug;138(2):141-9. doi: 10.1016/j.surg.2005.05.010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验